series-c-plus
Stage
2020
Founded
2
Investors
About
Terremoto Biosciences is a clinical-stage biotechnology company developing covalent small-molecule therapeutics, including AKT1-selective inhibitors, targeting oncology and genetic vascular diseases.
Explore Terremoto Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.